STOCK TITAN

Pacific Biosciences of California, Inc. Third Quarter 2020 Financial Results Call

(Neutral)
(Neutral)
Tags

Rhea-AI Summary

Pacific Biosciences of California (NASDAQ: PACB) announced it will hold its third-quarter 2020 conference call on November 2, 2020, at 4:30 PM ET. The call will be accessible via the company's website. As a leader in long-read sequencing technology, Pacific Biosciences aims to empower life scientists by providing comprehensive genomic insights through its innovative SMRT Sequencing systems. The press release provides details for accessing the call and highlights the importance of their technology in scientific research.

Loading...
Loading translation...

Positive

  • Upcoming quarterly conference call scheduled for November 2, 2020.
  • Strong focus on empowering life scientists with advanced sequencing technology.

Negative

  • None.

News Market Reaction – PACB

+4.04%
+4.04% Session move

In the trading session that priced this news, PACB gained 4.04%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MENLO PARK, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial Results on Monday, November 2, 2020, at 4:30pm Eastern Time.

The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/.

Date: November 2, 2020

Time: 4:30pm ET

Listen via Internet: https://investor.pacificbiosciences.com/

Toll-free: 888.366.7247

International: 707.287.9330

Conference ID: 5173038

Replay: https://investor.pacificbiosciences.com

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology. For more information please visit www.pacb.com and follow @PacBio.

Contact: Pacific Biosciences

Trevin Rard
650.521.8450
ir@pacificbiosciences.com

FAQ

When is Pacific Biosciences' third-quarter 2020 financial results call?

The call is scheduled for November 2, 2020, at 4:30 PM ET.

How can I access the Pacific Biosciences conference call?

The conference call can be accessed via the Pacific Biosciences website.

What technology does Pacific Biosciences use for sequencing?

Pacific Biosciences uses Single Molecule, Real-Time (SMRT) Sequencing technology.